We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been included in the Stanford University database of the world’s top 2% scientists, published by Elsevier. This prestigious recognition places Dr. Zanos among an elite group of researchers globally and reflects the significant impact of our laboratory’s research contributions to the field of neuropharmacology.

The Stanford database represents a comprehensive analysis of scientific impact across all academic disciplines worldwide. Scientists are evaluated based on citation impact, research contributions as lead author, field-normalized metrics that account for disciplinary differences, and long-term research influence. Being listed in this database demonstrates that the work conducted in our laboratory has made meaningful contributions to advancing our understanding of translational neuropharmacology and has influenced the broader scientific community.

This achievement represents not only Dr. Zanos’ individual research excellence but also the collective efforts of our entire laboratory team, including current and former graduate students, postdoctoral researchers, and collaborators who have contributed to our research program over the years. The recognition underscores the laboratory’s commitment to conducting high-impact research that bridges basic neuroscience with clinical applications.

For more information, visit: https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw/8